Overall survival (OS) in metastatic renal cell carcinoma (mRCC) sequentially treated with different targeted therapies (TTs): Results from a large cohort of patients

被引：0
|
作者：
Procopio, Giuseppe
Verzoni, Elena
Iacovelli, Roberto
Testa, Isabella
Salvioni, Roberto
Nicolai, Nicola
Porcu, Luca
De Braud, Filippo G.
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Univ Roma La Sapienza, Oncol Unit, Dept Radiol Oncol & Human Pathol, Rome, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
[4] Mario Negri Inst Pharmacol Res, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4629
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Conditional survival (CS) for patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy (TT): Results from the International mRCC Database Consortium.
    Choueiri, Toni K.
    Xie, Wanling
    Harshman, Lauren Christine
    Bjarnason, Georg A.
    Knox, Jennifer J.
    MacKenzie, Mary J.
    Wood, Lori
    Vaishampayan, Ulka N.
    Tan, Min-Han
    Rha, Sun Young
    Donskov, Frede
    Agarwal, Neeraj
    Kollmannsberger, Christian K.
    North, Scott A.
    Rini, Brian I.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [42] Overall survival (OS) in renal cell carcinoma (RCC) before and after the introduction of targeted therapies (TTs): A Norwegian population-based study (2000-2011).
    Klepp, Olbjorn Harald
    Johannesen, Tom Borge
    Oldenburg, Jan
    Torgersen, Knut Martin
    Kowalski, Jan
    Solli, Oddvar
    Sandin, Rickard
    Beisland, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [43] Evaluating intermediate endpoints (IE) for overall survival (OS) in metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI): An IMDC study.
    Saliby, Renee Maria
    Xie, Wanling
    Wells, J. Connor
    Saad, Eddy
    Eid, Marc
    Labaki, Chris
    Semaan, Karl
    Ferrier, Evan
    Lemelin, Audreylie
    Suarez, Cristina
    Ruiz-Morales, Jose Manuel
    Powles, Thomas
    Wood, Lori
    Ebrahimi, Hedyeh
    de Velasco, Guillermo
    Takemura, Kosuke null
    Agarwal, Neeraj
    Braun, David A.
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 400 - 400
  • [44] Prognostic Factors of Survival for Patients With Metastatic Renal Cell Carcinoma With Brain Metastases Treated With Targeted Therapy: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
    Vickers, Michael M.
    Al-Harbi, Hulayel
    Choueiri, Toni K.
    Kollmannsberger, Christian
    North, Scott
    MacKenzie, Mary
    Knox, Jennifer J.
    Rini, Brian I.
    Heng, Daniel Y. C.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (03) : 311 - 315
  • [45] Impact of Targeted Therapies on Muscle Loss and Adipose Tissue in Metastatic Renal Cell Carcinoma (mRCC)
    Antoun, S.
    Albiges, L.
    Iacovelli, R.
    Loriot, Y.
    Merad-Taoufik, M.
    Fizazi, K.
    Martin, L.
    Baracos, V.
    Escudier, B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S522 - S523
  • [46] Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Dudani, Shaan
    de Velasco, Guillermo
    Wells, Connor
    Gan, Chun Loo
    Donskov, Frede
    Porta, Camillo
    Fraccon, Anna
    Pasini, Felice
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Pal, Sumanta K.
    Hotte, Sebastien J.
    Lalani, Aly-Khan A.
    Yuasa, Takeshi
    Kanesvaran, Ravindran
    Reaume, M. Neil
    Canil, Christina M.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [47] Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies
    Kroeger, Nils
    Pantuck, Allan J.
    Wells, J. Connor
    Lawrence, Nicola
    Broom, Reuben
    Kim, Jenny J.
    Srinivas, Sandy
    Yim, Jessica
    Bjarnason, Georg A.
    Templeton, Arnoud
    Knox, Jennifer
    Bernstein, Ezra
    Smoragiewicz, Martin
    Lee, Jae
    Rini, Brian I.
    Vaishampayan, Ulka N.
    Woodm, Lori A.
    Beuselinck, Benoit
    Donskov, Frede
    Choueiri, Toni K.
    Heng, Daniel Y.
    EUROPEAN UROLOGY, 2015, 68 (03) : 506 - 515
  • [48] Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma
    Nouhaud, Francois-Xavier
    Pfister, Christian
    Defortescu, Guillaume
    Giwerc, Anthony
    Charbit, David
    Gouerant, Sophie
    Sabourin, Jean-Christophe
    Di Fiore, Frederic
    ANTI-CANCER DRUGS, 2015, 26 (08) : 866 - 871
  • [49] Have Molecularly Targeted Therapies Improved Overall Survival in Renal Cell Carcinoma?
    Choueiri, Michel
    Jonasch, Eric
    CURRENT ONCOLOGY REPORTS, 2011, 13 (03) : 153 - 156
  • [50] Have Molecularly Targeted Therapies Improved Overall Survival in Renal Cell Carcinoma?
    Michel Choueiri
    Eric Jonasch
    Current Oncology Reports, 2011, 13
12345